Comparison of OraQuick HCV Rapid Antibody Test and Standard Serologic Screening for Hepatitis C: Validity, Acceptability and Impact on Linkage to Care

Clinical trial NCT02084719 · TERMINATED

Trial details

NCT number: NCT02084719
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Active or Ex-injection Drug Users Indication of Hepatitis C Screening

Start date: 2014-03-01
Primary completion: 2016-04-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.